Talk:Colony stimulating factor 1 receptor
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Merger with Macrophage colony-stimulating factor receptor
editColony stimulating factor 1 receptor and Macrophage colony-stimulating factor receptor are the same protein, so these pages should be combined. Which name should be used though? ~ Ciar ~ (Talk to me!) 06:13, 21 January 2009 (UTC)
- I agree that these two articles should be merged. Since the official HUGO gene/protein name is CSF1R, I would vote for Colony stimulating factor 1 receptor. Cheers. Boghog2 (talk) 20:26, 21 January 2009 (UTC)
- Done! Thanks for the input. ~ Ciar ~ (Talk to me!) 21:28, 25 January 2009 (UTC)
As a drug target
editThey are found on Tumor-associated macrophages, Could add : Cabiralizumab (cabira; FPA-008) is a monoclonal antibody that targets/depletes Tumor-associated macrophages (TAMs) (by inhibiting CSF1R6),[1] and is in early clinical trials for metastatic pancreatic cancer.[2][3] - Rod57 (talk) 01:34, 24 November 2017 (UTC)
References
- ^ A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).
- ^ A Study to of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread
- ^ Novel Combination Shows Promising Responses in Pancreatic Cancer Nov 2017
Wiki Education assignment: Systems Pharmacology I 2022
edit
This article was the subject of a Wiki Education Foundation-supported course assignment, between 13 September 2022 and 12 December 2022. Further details are available on the course page. Student editor(s): Jgsrosa1 (article contribs).
— Assignment last updated by Jgsrosa1 (talk) 14:08, 28 September 2022 (UTC)